FCB Health Network President and CEO Dana Maiman today announced Jenna Brownstein has joined FCB Health New York as Group Management Director. Reporting to Maiman, Brownstein will lead teams in providing the agency’s best-in-class services to existing clients, while bringing its world-renowned excellence to new business prospects.
“I’ve greatly admired FCB Health New York for many years, and I couldn’t be more excited to finally join the team and use my passion and experience to bring meaningful benefits to our clients,” said Brownstein. “The ‘Never Finished’ mantra of relentless innovation spoke volumes to me, aligning so well with the way I approach business challenges, partner with clients and build teams. There’s a reason FCB is revered by competitors and clients alike!”
Brownstein brings to FCB Health New York over 20 years of experience in building and launching specialty products – like neuromodulation devices and growth hormones – as well as global powerhouse brands – like Singulair, Taxotere and quadrivalent flu vaccines. Before joining FCB Health New York, Jenna formed and led integrated teams across several key client groups at W2O. Previously, she held leadership positions at Ogilvy, Sudler & Hennessey, Medicus/Saatchi & Saatchi and JUICE. She has spearheaded a broad range of initiatives, including youth suicide prevention initiatives, inaugural mentorship programs, executive intern sponsorships and cross-discipline leadership pilot programs. Jenna has earned numerous industry accolades, including the Healthcare Businesswomen’s Association (HBA) Rising Star, Publicis Leadership Award and WPP Future Leaders Award.
“Whether she is working on huge blockbusters or small biotechs, Jenna always puts her clients first and manages to anticipate their needs,” said Maiman. “That is exactly how we do business here at FCB Health New York.”